Ensuring global access to COVID-19 vaccines

Lancet. 2020 May 2;395(10234):1405-1406. doi: 10.1016/S0140-6736(20)30763-7. Epub 2020 Mar 31.

Authors

Gavin Yamey¹, Marco Schäferhoff², Richard Hatchett³, Muhammad Pate⁴, Feng Zhao⁴, Kaci Kennedy McDade⁵

Affiliations

¹ Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC 27708, USA. Electronic address: gavin.yamey@duke.edu.
² Open Consultants, Berlin, Germany.
³ Coalition for Epidemic Preparedness Innovations, London, UK.
⁴ World Bank Group, Washington, DC, USA.
⁵ Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC 27708, USA.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Vaccines
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Drug Development / economics
Drug Industry
Global Health*
Health Services Accessibility*
Health Services Needs and Demand
Humans
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Resource Allocation*
SARS-CoV-2
Viral Vaccines*

Substances

COVID-19 Vaccines
Viral Vaccines